Skip to main content
PMC home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1989 Jun;52(6):701–708. doi: 10.1136/jnnp.52.6.701

A pathological study of the association between Lewy body disease and Alzheimer's disease.

W R Gibb 1, C Q Mountjoy 1, D M Mann 1, A J Lees 1
PMCID: PMC1032019  PMID: 2545826

Abstract

The possibility of an association between Parkinson's disease and Alzheimer's disease has been examined by studying the age-specific prevalence of Lewy bodies in the substantia nigra in a group of 273 control cases without Parkinson's disease and 121 cases of Alzheimer's disease. The substantia nigra was also studied in 14 cases of Down's syndrome, 13 of which had cortical Alzheimer pathology. Twelve (7.8%) of the controls aged over 60 years showed nigral Lewy bodies. There was mild nerve cell degeneration and/or an extranigral distribution of Lewy bodies, suggestive of presymptomatic Parkinson's disease. Twenty five (22.5%) of the Alzheimer's disease cases over 60 years showed Lewy bodies, but only 14 (14.0%) of these had mild nigral cell loss consistent with presymptomatic Parkinson's disease. No case of Down's syndrome had Lewy bodies. Counts of tangles and plaques in hippocampus, frontal and temporal cortex were lower in cases of Alzheimer's disease with Lewy bodies compared with those without, but cortical choline acetyltransferase (ChAT) activities were similar. This suggests that Lewy body degeneration in the nucleus basalis of Meynert contributes to the deficit of cortical ChAT, but not to the cortical Alzheimer pathology. The relatively small difference in the prevalence of Lewy bodies between controls and Alzheimer's disease could be explained by the additive effects of Lewy body and tangle pathology causing dementia, rather than a greater than chance association between Parkinson's disease and Alzheimer's disease.

Full text

PDF
701

Images in this article

702Image
on p.702
703Image
on p.703
704Image
on p.704

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aherne W. A., Diggle P. J. The estimation of neuronal population density by a robust distance method. J Microsc. 1978 Dec;114(3):285–293. doi: 10.1111/j.1365-2818.1978.tb00138.x. [DOI] [PubMed] [Google Scholar]
  2. Alvord E. C., Jr, Forno L. S., Kusske J. A., Kauffman R. J., Rhodes J. S., Goetowski C. R. The pathology of Parkinsonism: a comparison of degenerations in cerebral cortex and brainstem. Adv Neurol. 1974;5:175–193. [PubMed] [Google Scholar]
  3. Beppu H., Nagaoka M., Tanaka R. Analysis of cerebellar motor disorders by visually-guided elbow tracking movement. 2. Contribution of the visual cues on slow ramp pursuit. Brain. 1987 Feb;110(Pt 1):1–18. doi: 10.1093/brain/110.1.1. [DOI] [PubMed] [Google Scholar]
  4. Bernheimer H., Birkmayer W., Hornykiewicz O., Jellinger K., Seitelberger F. Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. J Neurol Sci. 1973 Dec;20(4):415–455. doi: 10.1016/0022-510x(73)90175-5. [DOI] [PubMed] [Google Scholar]
  5. Boller F., Mizutani T., Roessmann U., Gambetti P. Parkinson disease, dementia, and Alzheimer disease: clinicopathological correlations. Ann Neurol. 1980 Apr;7(4):329–335. doi: 10.1002/ana.410070408. [DOI] [PubMed] [Google Scholar]
  6. Brown R. G., Marsden C. D. How common is dementia in Parkinson's disease? Lancet. 1984 Dec 1;2(8414):1262–1265. doi: 10.1016/s0140-6736(84)92807-1. [DOI] [PubMed] [Google Scholar]
  7. Clark A. W., White C. L., 3rd, Manz H. J., Parhad I. M., Curry B., Whitehouse P. J., Lehmann J., Coyle J. T. Primary degenerative dementia without Alzheimer pathology. Can J Neurol Sci. 1986 Nov;13(4 Suppl):462–470. doi: 10.1017/s0317167100037136. [DOI] [PubMed] [Google Scholar]
  8. Cobb W. A., Marshall J., Scaravilli F. Long survival in subacute sclerosing panencephalitis. J Neurol Neurosurg Psychiatry. 1984 Feb;47(2):176–183. doi: 10.1136/jnnp.47.2.176. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Cross R. B. Demonstration of neurofibrillary tangles in paraffin sections: a quick and simple method using a modification of Palmgren's method. Med Lab Sci. 1982 Jan;39(1):67–69. [PubMed] [Google Scholar]
  10. De León G. A., Grover W. D., Huff D. S. Neuropathologic changes in ataxia-telangiectasia. Neurology. 1976 Oct;26(10):947–951. doi: 10.1212/wnl.26.10.947. [DOI] [PubMed] [Google Scholar]
  11. Dooling E. C., Schoene W. C., Richardson E. P., Jr Hallervorden-Spatz syndrome. Arch Neurol. 1974 Jan;30(1):70–83. doi: 10.1001/archneur.1974.00490310072012. [DOI] [PubMed] [Google Scholar]
  12. Elble R. J. Physiologic and essential tremor. Neurology. 1986 Feb;36(2):225–231. doi: 10.1212/wnl.36.2.225. [DOI] [PubMed] [Google Scholar]
  13. Gaspar P., Gray F. Dementia in idiopathic Parkinson's disease. A neuropathological study of 32 cases. Acta Neuropathol. 1984;64(1):43–52. doi: 10.1007/BF00695605. [DOI] [PubMed] [Google Scholar]
  14. Gibb W. R., Lees A. J. The significance of the Lewy body in the diagnosis of idiopathic Parkinson's disease. Neuropathol Appl Neurobiol. 1989 Jan-Feb;15(1):27–44. doi: 10.1111/j.1365-2990.1989.tb01147.x. [DOI] [PubMed] [Google Scholar]
  15. Godridge H., Reynolds G. P., Czudek C., Calcutt N. A., Benton M. Alzheimer-like neurotransmitter deficits in adult Down's syndrome brain tissue. J Neurol Neurosurg Psychiatry. 1987 Jun;50(6):775–778. doi: 10.1136/jnnp.50.6.775. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Hakim A. M., Mathieson G. Dementia in Parkinson disease: a neuropathologic study. Neurology. 1979 Sep;29(9 Pt 1):1209–1214. doi: 10.1212/wnl.29.9_part_1.1209. [DOI] [PubMed] [Google Scholar]
  17. Jellinger K., Grisold W. Cerebral atrophy in Parkinson syndrome. Exp Brain Res. 1982;Suppl 5:26–35. doi: 10.1007/978-3-642-68507-1_5. [DOI] [PubMed] [Google Scholar]
  18. Jellinger K., Riederer P. Dementia in Parkinson's disease and (pre) senile dementia of Alzheimer type: morphological aspects and changes in the intracerebral MAO activity. Adv Neurol. 1984;40:199–210. [PubMed] [Google Scholar]
  19. Joachim C. L., Morris J. H., Selkoe D. J. Clinically diagnosed Alzheimer's disease: autopsy results in 150 cases. Ann Neurol. 1988 Jul;24(1):50–56. doi: 10.1002/ana.410240110. [DOI] [PubMed] [Google Scholar]
  20. Leverenz J., Sumi S. M. Parkinson's disease in patients with Alzheimer's disease. Arch Neurol. 1986 Jul;43(7):662–664. doi: 10.1001/archneur.1986.00520070020010. [DOI] [PubMed] [Google Scholar]
  21. Mann D. M., Yates P. O., Marcyniuk B. Some morphometric observations on the cerebral cortex and hippocampus in presenile Alzheimer's disease, senile dementia of Alzheimer type and Down's syndrome in middle age. J Neurol Sci. 1985 Jul;69(3):139–159. doi: 10.1016/0022-510x(85)90129-7. [DOI] [PubMed] [Google Scholar]
  22. Mann D. M., Yates P. O., Marcynuik B. Age and Alzheimer's disease. Lancet. 1984 Feb 4;1(8371):281–282. doi: 10.1016/s0140-6736(84)90155-7. [DOI] [PubMed] [Google Scholar]
  23. Mountjoy C. Q., Roth M., Evans N. J., Evans H. M. Cortical neuronal counts in normal elderly controls and demented patients. Neurobiol Aging. 1983 Spring;4(1):1–11. doi: 10.1016/0197-4580(83)90048-9. [DOI] [PubMed] [Google Scholar]
  24. Nakano I., Hirano A. Parkinson's disease: neuron loss in the nucleus basalis without concomitant Alzheimer's disease. Ann Neurol. 1984 May;15(5):415–418. doi: 10.1002/ana.410150503. [DOI] [PubMed] [Google Scholar]
  25. Olson M. I., Shaw C. M. Presenile dementia and Alzheimer's disease in mongolism. Brain. 1969 Mar;92(1):147–156. doi: 10.1093/brain/92.1.147. [DOI] [PubMed] [Google Scholar]
  26. Pakkenberg H., Brody H. The number of nerve cells in the substantia nigra in paralysis agitans. Acta Neuropathol. 1965 Nov 18;5(2):320–324. doi: 10.1007/BF00686528. [DOI] [PubMed] [Google Scholar]
  27. Perry E. K., Curtis M., Dick D. J., Candy J. M., Atack J. R., Bloxham C. A., Blessed G., Fairbairn A., Tomlinson B. E., Perry R. H. Cholinergic correlates of cognitive impairment in Parkinson's disease: comparisons with Alzheimer's disease. J Neurol Neurosurg Psychiatry. 1985 May;48(5):413–421. doi: 10.1136/jnnp.48.5.413. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Rossor M. N., Garrett N. J., Johnson A. L., Mountjoy C. Q., Roth M., Iversen L. L. A post-mortem study of the cholinergic and GABA systems in senile dementia. Brain. 1982 Jun;105(Pt 2):313–330. doi: 10.1093/brain/105.2.313. [DOI] [PubMed] [Google Scholar]
  29. SIGWALD J., LAPRESLE J., RAVERDY P., RECONDO J. ATROPHIE C'ER'EBELLEUSE FAMILIALE AVEC ASSOCIATION DE L'ESIONS NIG'ERIENNES ET SPINALES. Presse Med. 1964 Feb 26;72:557–562. [PubMed] [Google Scholar]
  30. Sachdev H. S., Forno L. S., Kane C. A. Joseph disease: a multisystem degenerative disorder of the nervous system. Neurology. 1982 Feb;32(2):192–195. doi: 10.1212/wnl.32.2.192. [DOI] [PubMed] [Google Scholar]
  31. Sima A. A., Clark A. W., Sternberger N. A., Sternberger L. A. Lewy body dementia without Alzheimer changes. Can J Neurol Sci. 1986 Nov;13(4 Suppl):490–497. doi: 10.1017/s0317167100037185. [DOI] [PubMed] [Google Scholar]
  32. Tomlinson B. E., Blessed G., Roth M. Observations on the brains of demented old people. J Neurol Sci. 1970 Sep;11(3):205–242. doi: 10.1016/0022-510x(70)90063-8. [DOI] [PubMed] [Google Scholar]
  33. WOODARD J. S. Concentric hyaline inclusion body formation in mental disease analysis of twenty-seven cases. J Neuropathol Exp Neurol. 1962 Jul;21:442–449. doi: 10.1097/00005072-196207000-00012. [DOI] [PubMed] [Google Scholar]
  34. Wisniewski K. E., Dalton A. J., McLachlan C., Wen G. Y., Wisniewski H. M. Alzheimer's disease in Down's syndrome: clinicopathologic studies. Neurology. 1985 Jul;35(7):957–961. doi: 10.1212/wnl.35.7.957. [DOI] [PubMed] [Google Scholar]
  35. Wisniewski K. E., Wisniewski H. M., Wen G. Y. Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome. Ann Neurol. 1985 Mar;17(3):278–282. doi: 10.1002/ana.410170310. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES